BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 543513)

  • 1. The relationship between fibrinogen degradation products and cryofibrinogen.
    Komp DM; Donaldson MH
    Am J Pediatr Hematol Oncol; 1979; 1(2):99-102. PubMed ID: 543513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of DL and DH degradation products in the reactions of the plasmin hydrolysis of fibrinogen and fibrin].
    Rozenfel'd MA; Leonova VB; Khavkina LS
    Izv Akad Nauk SSSR Biol; 1991; (3):334-42. PubMed ID: 1835465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Differentiation of fibrinolysis and fibrinogenolysis by analysis of FDP fragments].
    Okumura N; Furuwatari C; Ishikawa S; Furihata K; Katsuyama T; Kanai M; Nakahata T; Saitoh H
    Rinsho Byori; 1992 Jul; 40(7):789-94. PubMed ID: 1507499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological behavior of higher molecular weight products of fibrinolysis.
    Chang ML; Bang NU
    J Lab Clin Med; 1977 Jul; 90(1):216-26. PubMed ID: 874368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis.
    Weitz JI; Leslie B; Ginsberg J
    J Clin Invest; 1991 Mar; 87(3):1082-90. PubMed ID: 1900308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunoglobulins A, M and G, fibrinogen degradation products (FFDP) and alkaline phosphatase activity in the cerebrospinal fluid in differential diagnosis of meningitis in children].
    Rudobielska M; Szafrańska M; Zoch-Zwierz W; Myśliwiec B
    Pol Tyg Lek; 1980 Aug; 35(34):1293-5. PubMed ID: 7443556
    [No Abstract]   [Full Text] [Related]  

  • 7. Fibrinogen, fibrin, and FDP induce C-reactive protein generation in rat vascular smooth muscle cells: pro-inflammatory effect on atherosclerosis.
    Guo F; Liu J; Wang C; Liu N; Lu P
    Biochem Biophys Res Commun; 2009 Dec; 390(3):942-6. PubMed ID: 19852936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinogen, fibrin(ogen) degradation products and fibrinopeptide A in pleural effusions. High turnover of fibrinogen in pleurisy.
    Widström O; Kockum C; Nilsson BS
    Scand J Respir Dis; 1978 Aug; 59(4):210-5. PubMed ID: 694476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of fibronectin on cryoprecipitate formation in rheumatoid arthritis and systemic lupus erythematosus.
    Beaulieu AD; Valet JP; Strevey J
    Arthritis Rheum; 1981 Nov; 24(11):1383-8. PubMed ID: 7317115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum protein profiles in thermal burns. I. Serum electrophoretic patterns, immunoglobulins, and transport proteins.
    Daniels JC; Larson DL; Abston S; Ritzmann SE
    J Trauma; 1974 Feb; 14(2):137-52. PubMed ID: 4130043
    [No Abstract]   [Full Text] [Related]  

  • 11. A quantitative enzyme immunoassay for primary fibrinogenolysis products in plasma.
    Koppert PW; Kuipers W; Hoegee-de Nobel B; Brommer EJ; Koopman J; Nieuwenhuizen W
    Thromb Haemost; 1987 Feb; 57(1):25-8. PubMed ID: 2438796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophoretic and quantitative studies on serum proteins in thyroid diseases.
    Miklaszewska M; Checińska Z
    Mater Med Pol; 1973; 5(4):250-4. PubMed ID: 4133321
    [No Abstract]   [Full Text] [Related]  

  • 13. Investigations of the role of immunological mechanisms in spinal muscular atrophy.
    Jezierska K
    Pol Med J; 1972; 11(5):1319-25. PubMed ID: 4119323
    [No Abstract]   [Full Text] [Related]  

  • 14. [Results of immunological studies on cryoprecipitates].
    Schneider D; Wegner H
    Z Gesamte Inn Med; 1970 Jul; 25(13):581-6. PubMed ID: 5002042
    [No Abstract]   [Full Text] [Related]  

  • 15. Correlation between gamma globulin levels and immunoglobulin IgG, IgA and IgM concentrations in blood serum.
    Plesnicar S
    Acta Med Iugosl; 1973; 27(5):427-34. PubMed ID: 4129695
    [No Abstract]   [Full Text] [Related]  

  • 16. [Fluctuation of plasma levels of fibrinogen degradation products, fibrin degradation products and total fibrin/fibrinogen degradation products in patients with DIC].
    Isogai N; Kuroso K; Fujimaki M; Yorifuji H; Fukutake K
    Rinsho Byori; 1993 Dec; 41(12):1349-52. PubMed ID: 8295346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The antifibrinolytic action of the D-dimer fragment].
    Rozenfel'd MA; Khavkina LS; Leonova VB; Gershkovich KB; Vasil'eva MV
    Izv Akad Nauk SSSR Biol; 1989; (6):855-61. PubMed ID: 2621282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific identification of urinary fibrinogen, fibrinogen degradation products, and cross-linked fibrin degradation products in renal diseases and after renal allotransplantation.
    Scott WL; Francis CW; Knutson DW; Marder VJ
    J Lab Clin Med; 1986 Jun; 107(6):534-43. PubMed ID: 3519810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Behavior of immunoglobulins. (IgA, IgG, IgM), of the C'3 and of the alpha globulins (alpha-1-antitrypsin, alpha-1-macroglobulin, haptoglobin, alpha-1-glyco-protein acid) in the rheumatic disease in infancy].
    Quaglia P; Pedrinazzi RC; Stangalini A
    Minerva Pediatr; 1971 May; 23(19):861-7. PubMed ID: 4104511
    [No Abstract]   [Full Text] [Related]  

  • 20. The fibrinogenolytic activity of purified tryptase from human lung mast cells.
    Schwartz LB; Bradford TR; Littman BH; Wintroub BU
    J Immunol; 1985 Oct; 135(4):2762-7. PubMed ID: 3161948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.